The industry’s mRNA alliance is demanding steady FDA leadership, warning that the current “unprecedented turmoil” at the ...

Even supporters of mRNA vaccination against COVID-19 might be surprised at just how much higher death rates are among the ...

How can doctors talk about the net benefits of COVID shots if they won’t acknowledge the worst risk? On the Friday after ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

Vaccinated adults had a 74 percent lower risk of dying from COVID-19—and a 25 percent lower risk of dying, period.

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel ...

The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

Correcting misinformation after it has gone viral is a common way of informing the public that what they've encountered may ...

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...